Depression in cirrhosis - a prospective evaluation of the prevalence, predictors and development of a screening nomogram.

Abstract

Depression is associated with substantial morbidity and mortality in cirrhosis, but is underdiagnosed and undertreated. Using the Mini International Neuropsychiatric Interview (MINI) as a gold-standard, to determine prevalence, predictors, and outcomes of depression, and to develop a screening nomogram for use in cirrhosis patients. Cirrhotic outpatients 18-80years of age, not on anti-depressants, were consecutively recruited from liver clinics at three tertiary care hospitals. Baseline health-related quality of life (HRQoL) and frailty were determined by the chronic liver disease questionnaire, EQ-VAS, Clinical Frailty Scale and Fried Frailty Criteria. Depression was identified using the MINI and participants were followed up to 6months to determine unplanned hospitalization/death. Of 305 patients, 62% were male; mean age 55(10) years; mean MELD 12.5(5), 61% Child Pugh B/C. Prevalence of depression 18% by MINI. Patients with depression had lower baseline HRQoL and higher frailty scores. Five independently predictive factors were used to develop a clinical nomogram for the diagnosis of clinical depression. These included three Hospital Anxiety and Depression Screening tool variables: "I have lost interest in my appearance" (adjusted odds ratio [aOR] 2.2, P=0.006), "I look forward with enjoyment to things" (aOR 2.0, P=0.02), "I feel cheerful" (aOR 2.8, P=0.002), and two demographic variables: younger age (aOR 0.92, P=0.001) and not being married or in a common-law relationship (aOR 0.30, P=0.008). Depression is common in patients with cirrhosis. It has a significant impact on HRQoL and functional status. The developed clinical nomogram is promising for the rapid screening of depression in patients with cirrhosis.